GSK pulls out of $20 billion race for Pfizer's consumer health-care business - CNBC

CNBC
GSK pulls out of $20 billion race for Pfizer's consumer health-care business
CNBC
GlaxoSmithKline has withdrawn from the race to buy Pfizer's consumer health-care business, the British company said. The move endangers an auction the U.S. drugmaker hoped would bring in as much as $20 billion. It was not immediately clear whether ...
GSK pulls out of $20 billion race for Pfizer consumer assets - ReutersReuters
Glaxo Surges After Withdrawing Bid for Pfizer Consumer-Health UnitBloomberg
First